FundedIQ
Artificial Intelligence

Eyenuk, Inc.: Funding, Investors & Team (Sep 2026)

Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.

www.eyenuk.com LinkedIn Los Angeles, United States 11-50 employees
Artificial Intelligence Diabetes Health Care Health Diagnostics Hospital Medical Medical Device Personal Health
Total raised
$54.6M
Rounds
3
Latest
Series A
Oct 2022

Eyenuk, Inc. has raised $54.6M across 3 funding rounds on record, the most recent a Series A of $26.0M announced in Oct 2022.

That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Eyenuk, Inc. Company Profile and Key Stats

Total funding raised
$54.6M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series A
$26.0M in Oct 2022
Employees
11-50
reported band
Headquarters
Los Angeles, United States

Latest funding round on record: Oct 2022.

Eyenuk, Inc. Funding Rounds

Date
Round
Amount
Series A
$26.0M
Undisclosed round
$22.4M
Undisclosed round
$6.2M

Eyenuk, Inc. raised $6.2M in an undisclosed round announced in Jul 2021.

1.1 years later, an undisclosed round of $22.4M was announced in Aug 2022.

2 months later, a Series A of $26.0M was announced in Oct 2022.

Eyenuk, Inc. Founders and Leadership Team

Name
Role
Contact
Kaushal Solanki
CEO
Locked

Contact details for the Eyenuk, Inc. team: 1 of 1 has an email address on file.

Start 14-day free trial →

Eyenuk, Inc. Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round
29,722
$7.5M
8,352
$15M

Eyenuk, Inc.'s latest round of $26.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Eyenuk, Inc. in Artificial Intelligence and Los Angeles

Companies Similar to Eyenuk, Inc.

Series A $20.0M

Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…

Series E $156M

Instinct is an artificial intelligence startup developing AI technology.

Series B $250M

Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…

Undisclosed round $15.0M

Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…

Series A $8.0M

Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…

Series A $150M

Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…

Series D $200M

Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…

Series B $200M

Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…

Series A $40.0M

Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…

Undisclosed round $26.1M

Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…

Series A $13.0M

Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…

Series C

Eyenuk, Inc. Funding FAQs

What does Eyenuk, Inc. do?

Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.

How much funding has Eyenuk, Inc. raised?

Eyenuk, Inc. has raised $54.6M across 3 rounds on record. The most recent is a Series A of $26.0M announced in Oct 2022.

When did Eyenuk, Inc. last raise funding?

Eyenuk, Inc.'s most recent funding round on record is a Series A of $26.0M, announced in Oct 2022.

Who is the CEO of Eyenuk, Inc.?

Kaushal Solanki is listed as CEO at Eyenuk, Inc..

Where is Eyenuk, Inc. headquartered?

Eyenuk, Inc. is based in Los Angeles, California, United States.

How many employees does Eyenuk, Inc. have?

Eyenuk, Inc. is in the 11-50 employee band.

How does Eyenuk, Inc.'s funding compare to other Artificial Intelligence startups?

Eyenuk, Inc.'s latest round of $26.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Eyenuk, Inc. Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eyenuk, Inc. is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.